Cognition Therapeutics Capital Expenditures (CapEx) Growth & History (CGTX)

Cognition Therapeutics's capital expenditures (capex) was $4,000 for fiscal 2024.

View full Cognition Therapeutics company overview

Cognition Therapeutics annual capital expenditures (capex) history

Cognition Therapeutics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$4,000−$143,000−97.28%
20232023-12-31$147,000−$24,000−14.04%
20222022-12-31$171,000$144,000+533.33%
20212021-12-31$27,000$17,000+170.00%
20202020-12-31$10,000

Cognition Therapeutics capital expenditures (capex) trends

Between the periods ended 2020-12-31 and 2024-12-31, Cognition Therapeutics's capital expenditures (capex) decreased from $10,000 to $4,000, a change of −$6,000. The latest reported quarter, Q4 2024, shows $1,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cognition Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about CGTX yet. Start the conversation.

Write the first post